Replies to post #436922 on Anavex Life Sciences Corp (AVXL)

[WilliamMunny]

Any you think that the rate of brain volume loss might not be considered a safety issue, and that the Data Safety Monitoring Board would not bother looking at it, or that if it were positive relative to placebo, it would just be ignored? Possible, I suppose, but it strikes me as odd.